|
|
|
|
LEADER |
02021nmm a2200373 u 4500 |
001 |
EB002009375 |
003 |
EBX01000000000000001172274 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
220131 ||| eng |
100 |
1 |
|
|a Hidalgo-Simon, Ana
|
245 |
0 |
0 |
|a Regulation of ATMPs in Europe
|h Elektronische Ressource
|b present and future
|c Ana Hidalgo-Simon
|
246 |
3 |
1 |
|a Regulation of advanced therapy medicinal products in Europe
|
260 |
|
|
|a London
|b Henry Stewart Talks
|c 2021, 2021
|
300 |
|
|
|a 1 streaming video file (37 min.)
|b color, sound
|
505 |
0 |
|
|a Contents: Introduction to ATMPs -- Route of approval in Europe -- Approved ATMPs 2009-2021 -- ATMPs: Challenges for regulators -- Challenges to be addressed during development -- What support tools developers can use -- Future challenges of ATMPs -- Potential bridges and solutions
|
610 |
1 |
4 |
|a European Medicines Agency
|
653 |
|
|
|a Gene therapy / Law and legislation / European Union countries
|
653 |
|
|
|a Cellular therapy / Law and legislation / European Union countries
|
653 |
|
|
|a Tissue engineering / Law and legislation / European Union countries
|
653 |
|
|
|a Drug development / organization & administration
|
653 |
|
|
|a Genetic Therapy / legislation & jurisprudence
|
653 |
|
|
|a Legislation, Medical / organization & administration
|
653 |
|
|
|a Patient Safety / legislation & jurisprudence
|
653 |
|
|
|a Clinical trials as topic / organization & administration
|
653 |
|
|
|a Medical laws and legislation / European Union countries
|
653 |
|
|
|a Tissue Engineering / legislation & jurisprudence
|
653 |
|
|
|a Cell- and Tissue-Based Therapy / standards
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b HST
|a Henry Stewart Talks
|
490 |
0 |
|
|a The biomedical & life sciences collection
|
500 |
|
|
|a Animated audio-visual presentation with synchronized narration. - Title from title frames. - Mode of access: World Wide Web
|
856 |
4 |
0 |
|u https://hstalks.com/bs/4827
|x Verlag
|z Streaming video file
|
082 |
0 |
|
|a 570
|